+0.04
+0.38%
| Symbol | Value ($) |
|---|---|
| Morningstar Rating | |
| Previous Close | 10.56 |
| Category | Health |
| Net Assets | 743.78 Mil |
| Yield | 1.97% |
| Morningstar Risk | Below Average |
| Morningstar Return | Below Average |
- Last NAV update 5/21/2013 4:00 PM ET
| NA |
|---|
| The investment seeks long-term capital growth by investing in a worldwide and diversified portfolio of health sciences companies. The fund normally invests at least 80% of its net assets in securities of companies principally engaged in the discovery, development, production or distribution of products related to scientific advances in health care, including biotechnology, pharmaceuticals, diagnostics, managed health care and medical equipment and supplies. It concentrates (that is, invests at least 25% of its assets) its investments in medical research and the health care industry. The fund may invest up to 5% of its total assets in royalty bonds. |
| 2009 | 2010 | 2011 | 2012 | 2013 | |
|---|---|---|---|---|---|
| Return | 9.89% | 11.13% | 4.75% | 15.49% | 20.32% |
| Value ($) | 10,989.00 | 12,212.08 | 12,792.15 | 14,773.65 | 17,775.66 |
- Year to date performance as of 5/20/2013 8:00 PM ET
| Symbol | Value ($) |
|---|---|
| Fund Family | Eaton Vance |
| Fund Manager | Samuel Isaly |
| Tenure (Years) | 28 |
| Fund Status | Open |
| Minimum Initial Purchase | 1,000.00 |
| Minimum IRA Investment | NA |
| Front Load | 5.75 |
| Expense Ratio | 1.44% |
| Symbol | Value ($) |
|---|---|
| 1 Month | 2.72% |
| 3 Months | 11.28% |
| 1 Year | 31.33% |
| 3 Years* | 17.95% |
| 5 Years* | 11.50% |
- * Annualized returns
- Performance as of 5/20/2013 8:00 PM ET
| ETHSX | Health | |
|---|---|---|
| 5-Yr Return | 11.50% | 12.34% |
| Sharpe Ratio | 1.04 | 1.13 |
| Net Assets | 743.78 Mil | 504.34 Mil |
| Avg Market Cap | 19.19 Bil | 18.61 Bil |
| Avg P/E | 18.80 | 18.60 |
| Portfolio Turnover | 63 | 48 |
| Symbol | Value ($) |
|---|---|
| Stocks | 100.02% |
| Cash | 0.00% |
| Fixed Income | 0.00% |
| Other | -0.02% |
| NAME | % NET ASSETS |
|---|---|
| Roche Holding AG | 6.19% |
| Sanofi | 5.43% |
| Gilead Sciences Inc | 5.25% |
| Pfizer Inc | 5.10% |
| HCA Holdings Inc | 4.24% |
| Bristol-Myers Squibb Company | 3.69% |
| Amgen Inc | 3.41% |
| Merck & Co Inc | 3.08% |
| Mylan Inc | 2.94% |
| ONO Pharmaceutical Co., Ltd. | 2.80% |
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.
